Total Payments
$2,750
2024 Payments
$21.49
Companies
37
Transactions
155
Medicare Patients
5,626
Medicare Billing
$187,700
Payment Breakdown by Category
Food & Beverage$2,618 (95.2%)
Education$131.98 (4.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,618 | 153 | 95.2% |
| Education | $131.98 | 2 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $311.64 | 12 | $0 (2023) |
| Amgen Inc. | $274.25 | 14 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $230.83 | 13 | $0 (2021) |
| Seagen Inc. | $191.26 | 9 | $0 (2022) |
| BeiGene USA, Inc. | $168.89 | 11 | $0 (2022) |
| Genentech USA, Inc. | $140.57 | 8 | $0 (2022) |
| Janssen Biotech, Inc. | $132.71 | 11 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $129.33 | 10 | $0 (2022) |
| Daiichi Sankyo Inc. | $129.28 | 3 | $0 (2021) |
| PFIZER INC. | $121.24 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.49 | 1 | ABBVIE INC. ($21.49) |
| 2023 | $53.92 | 3 | Pharmacyclics LLC, An AbbVie Company ($36.07) |
| 2022 | $708.71 | 35 | Pharmacyclics LLC, an AbbVie Company ($182.33) |
| 2021 | $1,966 | 116 | Amgen Inc. ($245.61) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 04/05/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: ONCOLOGY | ||||||
| 03/30/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Oncology | ||||||
| 09/12/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Hematology | ||||||
| 07/28/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, MEKINIST | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: ONCOLOGY | ||||||
| 05/05/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2022 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Oncology | ||||||
| 04/12/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| Category: Oncology | ||||||
| 04/07/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Oncology | ||||||
| 03/30/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.89 | General |
| Category: Oncology | ||||||
| 03/29/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Oncology | ||||||
| 03/16/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2022 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 17 | 943 | 1,385 | $78,877 | $16,295 |
| 2021 | 32 | 2,236 | 13,387 | $405,720 | $90,176 |
| 2020 | 31 | 2,447 | 22,740 | $569,489 | $81,229 |
Total Patients
5,626
Total Services
37,512
Medicare Billing
$187,700
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 47 | $18,659 | $3,469 | 18.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 20 | 29 | $13,189 | $2,241 | 17.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 193 | 227 | $6,721 | $1,890 | 28.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 200 | 239 | $6,501 | $1,828 | 28.1% |
| 80076 | Liver function blood test panel | Office | 2022 | 191 | 224 | $6,406 | $1,801 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 44 | $11,738 | $1,458 | 12.4% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 49 | 54 | $2,576 | $732.13 | 28.4% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 17 | 34 | $3,364 | $571.49 | 17.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 11 | 12 | $2,715 | $486.68 | 17.9% |
| 83550 | Iron binding capacity | Office | 2022 | 48 | 53 | $1,621 | $460.82 | 28.4% |
| 83540 | Iron level | Office | 2022 | 48 | 53 | $1,200 | $341.26 | 28.4% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2022 | 15 | 18 | $1,194 | $339.57 | 28.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 15 | 29 | $1,539 | $281.44 | 18.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 12 | 13 | $764.40 | $217.21 | 28.4% |
| 83735 | Magnesium level | Office | 2022 | 15 | 17 | $398.65 | $107.46 | 27.0% |
| J3490 | Unclassified drugs | Office | 2022 | 13 | 14 | $151.00 | $43.44 | 28.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 13 | 278 | $136.22 | $25.42 | 18.7% |
| J2505 | Injection, pegfilgrastim, 6 mg | Office | 2021 | 12 | 12 | $124,460 | $26,176 | 21.0% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 22 | 85 | $44,400 | $13,600 | 30.6% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2021 | 12 | 9,750 | $38,385 | $8,731 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 89 | $35,040 | $6,631 | 18.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 426 | 669 | $19,570 | $5,178 | 26.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 415 | 610 | $18,978 | $5,122 | 27.0% |
| 80076 | Liver function blood test panel | Office | 2021 | 405 | 588 | $17,746 | $4,783 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 94 | $24,832 | $4,691 | 18.9% |
About Anna Smith, FNP
Anna Smith, FNP is a Family healthcare provider based in Corinth, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2014. The National Provider Identifier (NPI) number assigned to this provider is 1891193264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Smith, FNP has received a total of $2,750 in payments from pharmaceutical and medical device companies, with $21.49 received in 2024. These payments were reported across 155 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,618).
As a Medicare-enrolled provider, Smith has provided services to 5,626 Medicare beneficiaries, totaling 37,512 services with total Medicare billing of $187,700. Data is available for 3 years (2020–2022), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Corinth, MS
- Active Since 12/16/2014
- Last Updated 12/16/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1891193264
Products in Payments
- IMBRUVICA (Drug) $406.04
- BRUKINSA (Drug) $168.89
- OPDIVO (Biological) $129.33
- KEYTRUDA (Biological) $121.23
- Enhertu (Drug) $102.72
- Kyprolis (Drug) $99.51
- LIBTAYO (Biological) $83.85
- TUKYSA (Drug) $70.05
- IMFINZI (Biological) $68.81
- IBRANCE (Drug) $67.18
- VENCLEXTA (Biological) $61.13
- HEMADY (Drug) $58.47
- PADCEV (Biological) $54.22
- XTANDI (Drug) $54.06
- CALQUENCE (Drug) $53.26
- LUMAKRAS (Drug) $52.70
- MEKINIST (Drug) $42.95
- TIBSOVO (Drug) $42.44
- LYNPARZA (Drug) $41.32
- KISQALI (Drug) $37.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Corinth
Phyllis Fiveash, Cfnp, CFNP
Family — Payments: $9,397
Family $9,397
Darrah Cooper
Family — Payments: $7,123
Family $7,123
Carrie Porterfield, Fnpc, FNPC
Family — Payments: $6,840
Family $6,840
Jessica Harkey, Fnpc, FNPC
Family — Payments: $6,547
Family $6,547
Laquita Bain, Fnp, FNP
Family — Payments: $6,336
Family $6,336
Ms. Misty Rowsey, Fnp-Bc, FNP-BC
Family — Payments: $6,061
Family $6,061